Browsing by Author "Gore, M. E."

Now showing items 1-2 of 2

    • Article  

      Population pharmacokinetic and dynamic analysis of the topoisomerase I inhibitor lurtotecan in phase II studies 

      Schellens, J. H. M.; Heinrich, B.; Lehnert, M.; Gore, M. E.; Kaye, Stanley B.; Dombernowsky, P.; Paridaens, R.; Oosterom, A. T. Van; Verweij, J.; Loos, W. J.; Calvert, H.; Pavlidis, Nicholas; Cortes-Funes, H.; Wanders, J.; Roelvink, M.; Sessa, Cristiana; Selinger, K.; Wissel, P. S.; Gamucci, T.; Hanauske, A. R. (2002)
      Population pharmacokinetic-dynamic analysis was prospectively integrated in a broad phase II program of lurtotecan (GI147211), a novel camptothecin derived topoisomerase I inhibitor, to determine the population pharmacokinetic ...
    • Article  

      Sunitinib treatment for longer than 2 years for renal cell carcinoma 

      Pickering, L. M.; Constantinidou, Anastasia; Larkin, J. M.; Sohaib, S. A.; Khatri, P.; Nathan, P. D.; Vinayan, A.; Ferguson, Trevor S.; Rose, S. St; Gore, M. E. (2010)